Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment
Federica Pizzo, Zaira Maroccia, Ivano Hammarberg Ferri, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6138-6138
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Characterization of Lung and Oral Microbiomes in Lung Cancer Patients Using Culturomics and 16S rRNA Gene Sequencing
Yi‐Fan Sun, Yuejiao Liu, Jianjie Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 28
Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues
Panoraia I. Siafaka, Ece Özcan Bülbül, Αndroulla N. Miliotou, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105381-105381
Closed Access | Times Cited: 9
Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies
Weici Liu, Zheshun Pi, Xiaokun Wang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104322-104322
Closed Access | Times Cited: 7
A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis
Sumel Ashique, Neeraj Mishra, Ashish Garg, et al.
Archivos de Bronconeumología (2024) Vol. 60, pp. S46-S58
Closed Access | Times Cited: 7
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC)
Teresa Del Giudice, Nicoletta Staropoli, Pierfrancesco Tassone, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1806-1806
Open Access | Times Cited: 5
Akkermansia muciniphila outer membrane protein regulates recruitment of CD8+ T cells in lung adenocarcinoma and through JAK–STAT signalling pathway
Yufen Xu, Xiaoli Tan, Qi Yang, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 5
Bacterial infection and microbiota in carcinogenesis and tumor development
Qiao Li
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
The traditional Chinese medicine and non-small cell lung cancer: from a gut microbiome perspective
Xuelin Wang, Liming Hou, Meng Cui, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Exploring lung cancer microenvironment: pathways and nanoparticle-based therapies
Arunabh Arandhara, Pallabi Bhuyan, Bhrigu Kumar Das
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Calcium Intake and Lung Cancer Risk: A Pooled Analysis of 12 Prospective Cohort Studies
Yumie Takata, Jae Jeong Yang, Danxia Yu, et al.
Journal of Nutrition (2023) Vol. 153, Iss. 7, pp. 2051-2060
Closed Access | Times Cited: 10
Lung microbiome: an emerging player in lung cancer pathogenesis and progression
Alexandra Karvela, Orsalia-Zoi Veloudiou, Anastasia Karachaliou, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 8, pp. 2365-2372
Closed Access | Times Cited: 10
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice
Gaofeng Fang, Shengquan Wang, Qianyao Chen, et al.
Neoplasia (2023) Vol. 45, pp. 100943-100943
Open Access | Times Cited: 9
A Combination of Two Probiotics, Lactobacillus sporogenes and Clostridium butyricum, Inhibits Colon Cancer Development: An In Vitro Study
Oana Budu, Christian Banciu, Iulia Pînzaru, et al.
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1692-1692
Open Access | Times Cited: 15
Gut Microbiota a Novel Source of Biomarkers for Immunotherapy in Non-small Cell Lung Cancer (NSCLC)
Teresa Del Giudice, Nicoletta Staropoli, Pierfrancesco Tassone, et al.
(2024)
Open Access | Times Cited: 2
Causal influence of gut microbiota on small cell lung cancer: a Mendelian randomization study
Wenjing Yang, X. Fan, Wangshu Li, et al.
The Clinical Respiratory Journal (2024) Vol. 18, Iss. 5
Open Access | Times Cited: 2
Exploring the microbiome: Uncovering the link with lung cancer and implications for diagnosis and treatment
Junqi Yi, Juanjuan Xiang, Jingqun Tang
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 3, pp. 161-170
Open Access | Times Cited: 5
Microbiome Sex-Related Diversity in Non-Muscle-Invasive Urothelial Bladder Cancer
Konrad Bilski, Natalia Żeber‐Lubecka, Maria Kulecka, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3595-3609
Open Access | Times Cited: 1
Bronchial Microbiota and the Stress Associated with Invasive Diagnostic Tests in Lung Cancer vs. Benign Pulmonary Diseases: A Cross-Sectional Study
Patricia Hogea, Emanuela Tudorache, Ovidiu Firă-Mlădinescu, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2419-2419
Open Access | Times Cited: 3
Cáncer de pulmón
Carlos Manzano, Álvaro Fuentes-Martín, María Zuil, et al.
Open Respiratory Archives (2023) Vol. 5, Iss. 3, pp. 100264-100264
Open Access | Times Cited: 3
The gut and lung microbiota in pulmonary tuberculosis: susceptibility, function, and new insights into treatment
Qiqi Zhuo, Xianyi Zhang, Kehong Zhang, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 12, pp. 1355-1364
Open Access | Times Cited: 3
Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors
Noelia Silva-Pilipich, Ángela Covo-Vergara, Cristian Smerdou
Cancers (2023) Vol. 15, Iss. 8, pp. 2352-2352
Open Access | Times Cited: 2
Narrative review: respiratory tract microbiome and never smoking lung cancer
Sydney Pindling, Madelyn Klugman, Qing Lan, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 8, pp. 4522-4529
Open Access | Times Cited: 2
Mechanisms underlying the effects, and clinical applications, of oral microbiota in lung cancer: current challenges and prospects
Qiong Ma, Xueke Li, Hua Jiang, et al.
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 5, pp. 631-652
Closed Access | Times Cited: 2
[Hypothesis of Genetic Diversity Selection in the Occurrence and Development of 
Lung Cancer: Molecular Evolution and Clinical Significance].
Baodong Liu
PubMed (2024) Vol. 26, Iss. 12, pp. 943-949
Closed Access
Microbes for lung cancer detection: feasibility and limitations
Sirui Zhou, Weijian Zhu, Hehua Guo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1 - Next Page

Scroll to top